Tiziana Life Sciences Ltd Decrease Through Impairment Contract Assets
Discontinued › Expense Statement › Operating Expenses
ifrs-full:DecreaseThroughImpairmentContractAssets · last filed 2022-05-23
| Period end | Decrease Through Impairment Contract Assets 12 month |
|---|---|
| 2020-12-31 | $279.00K 20-F · filed 2022-05-23 |